skip to main content
Idioma:
previous page 3 4 Resultados 5 6 7 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
41
Aspirin Therapy in Primary Cardiovascular Disease Prevention
Aspirin Therapy in Primary Cardiovascular Disease Prevention
Material Type:
Artigo 		Adicionar ao Meu Espaço

Aspirin Therapy in Primary Cardiovascular Disease Prevention

Halvorsen, Sigrun, MD ; Andreotti, Felicita, MD, PhD ; ten Berg, Jurriën M., MD ; Cattaneo, Marco, MD ; Coccheri, Sergio, MD ; Marchioli, Roberto, MD ; Morais, João, MD ; Verheugt, Freek W.A., MD ; De Caterina, Raffaele, MD, PhD

Journal of the American College of Cardiology, 2014-07, Vol.64 (3), p.319-327 [Periódico revisado por pares]

New York: Elsevier Limited

Texto completo disponível

Citações Citado por
42
Expanding the role of coagulation in arterial thrombosis: Evidence from animal models using a new factor Xa inhibitor
Expanding the role of coagulation in arterial thrombosis: Evidence from animal models using a new factor Xa inhibitor
Material Type:
Artigo 		Adicionar ao Meu Espaço

Expanding the role of coagulation in arterial thrombosis: Evidence from animal models using a new factor Xa inhibitor

Andreotti, Felicita ; Santucci, Eleonora

Thrombosis and haemostasis, 2008-04, Vol.99 (4), p.651-652 [Periódico revisado por pares]

Germany: Schattauer Verlag für Medizin und Naturwissenschaften

Texto completo disponível

Citações Citado por
43
Adjusted Indirect Meta-Analysis of Aspirin Plus Warfarin at International Normalized Ratios 2 to 3 Versus Aspirin Plus Clopidogrel After Acute Coronary Syndromes
Adjusted Indirect Meta-Analysis of Aspirin Plus Warfarin at International Normalized Ratios 2 to 3 Versus Aspirin Plus Clopidogrel After Acute Coronary Syndromes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjusted Indirect Meta-Analysis of Aspirin Plus Warfarin at International Normalized Ratios 2 to 3 Versus Aspirin Plus Clopidogrel After Acute Coronary Syndromes

Testa, Luca, MD ; Zoccai, Giuseppe Biondi, MD ; Porto, Italo, MD ; Trotta, Graziana, MD ; Agostoni, Pierfrancesco, MD ; Andreotti, Felicita, MD ; Crea, Filippo, MD

The American journal of cardiology, 2007-06, Vol.99 (12), p.1637-1642 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
44
Cardiac mortality, adequate power, and objective inclusion of the entire evidence are key to accurately define the long-term effect of revascularisation vs. medical therapy alone in stable coronary syndromes
Cardiac mortality, adequate power, and objective inclusion of the entire evidence are key to accurately define the long-term effect of revascularisation vs. medical therapy alone in stable coronary syndromes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cardiac mortality, adequate power, and objective inclusion of the entire evidence are key to accurately define the long-term effect of revascularisation vs. medical therapy alone in stable coronary syndromes

Navarese, Eliano P ; Andreotti, Felicita

European heart journal, 2021-12, Vol.42 (45), p.4699-4700 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
45
New EHJ Team on Thrombosis
New EHJ Team on Thrombosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

New EHJ Team on Thrombosis

European heart journal, 2022-01, Vol.43 (3), p.179-180 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
46
Diagnoses and outcomes in patients with suspected angina: what are they trying to tell us?
Diagnoses and outcomes in patients with suspected angina: what are they trying to tell us?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Diagnoses and outcomes in patients with suspected angina: what are they trying to tell us?

Andreotti, Felicita ; Crea, Filippo ; Sechtem, Udo

European heart journal, 2019-05, Vol.40 (18), p.1436-1439 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
47
Prolonged endogenous fibrinolysis predicts reduced survival after acute coronary syndromes
Prolonged endogenous fibrinolysis predicts reduced survival after acute coronary syndromes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prolonged endogenous fibrinolysis predicts reduced survival after acute coronary syndromes

Andreotti, Felicita ; Navarese, Eliano Pio ; Crea, Filippo

European heart journal, 2018-04, Vol.39 (13), p.1086-1088 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
48
New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes
New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes
Material Type:
Artigo 		Adicionar ao Meu Espaço

New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes

De Caterina, Raffaele, MD, PhD ; Husted, Steen, MD, DSc ; Wallentin, Lars, MD, PhD ; Andreotti, Felicita, MD, PhD ; Arnesen, Harald, MD ; Bachmann, Fedor, MD ; Baigent, Colin, MD ; Huber, Kurt, MD ; Jespersen, Jørgen, MD, DSc ; Kristensen, Steen Dalby, MD ; Lip, Gregory Y.H., MD ; Morais, João, MD ; Rasmussen, Lars Hvilsted, MD, PhD ; Siegbahn, Agneta, MD, PhD ; Verheugt, Freek W.A., MD ; Weitz, Jeffrey I., MD

Journal of the American College of Cardiology, 2012-04, Vol.59 (16), p.1413-1425 [Periódico revisado por pares]

New York: Elsevier Inc

Texto completo disponível

Citações Citado por
49
Antithrombotic Therapy for Patients With Atrial Fibrillation and Atherothrombotic Vascular Disease: Striking the Right Balance Between Efficacy and Safety
Antithrombotic Therapy for Patients With Atrial Fibrillation and Atherothrombotic Vascular Disease: Striking the Right Balance Between Efficacy and Safety
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antithrombotic Therapy for Patients With Atrial Fibrillation and Atherothrombotic Vascular Disease: Striking the Right Balance Between Efficacy and Safety

Patrono, Carlo ; Andreotti, Felicita

Circulation (New York, N.Y.), 2013-08, Vol.128 (7), p.684-686 [Periódico revisado por pares]

United States: by the American College of Cardiology Foundation and the American Heart Association, Inc

Texto completo disponível

Citações Citado por
50
Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial

Raal, Frederick J, Prof ; Honarpour, Narimon, MD ; Blom, Dirk J, MD ; Hovingh, G Kees, MD ; Xu, Feng, MS ; Scott, Rob, MD ; Wasserman, Scott M, MD ; Stein, Evan A, Prof

The Lancet (British edition), 2015-01, Vol.385 (9965), p.341-350 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
previous page 3 4 Resultados 5 6 7 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (302)
  2. Revistas revisadas por pares (315)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (331)
  2. Book Chapters  (3)
  3. Reports  (1)
  4. Livros  (1)
  5. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1994  (13)
  2. 1994Até2000  (30)
  3. 2001Até2007  (64)
  4. 2008Até2015  (112)
  5. Após 2015  (117)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (313)
  2. Japonês  (38)
  3. Italiano  (14)
  4. Espanhol  (6)
  5. Polonês  (4)
  6. Russo  (2)
  7. Português  (2)
  8. Alemão  (1)
  9. Norueguês  (1)
  10. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.